Viking Therapeutics Inc (VKTX) Implied Volatility Current

Tracking VKTX implied volatility helps you identify when options premiums on Viking Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Viking Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when VKTX IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Viking Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For VKTX, tracking metrics like VKTX IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on VKTX signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy.

The company was incorporated in 2012 and is headquartered in San Diego, California.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where VKTX implied volatility sits today versus where it has been. Our scanner ranks Viking Therapeutics Inc implied volatility against its historical range, surfaces extremes in VKTX IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Viking Therapeutics Inc IV is rich or cheap — measure it, then act on it.